Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2; no substantive changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding/status banner from the page, which previously warned that information might not be up to date and directed users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant content changes detected. The page continues to display study details, eligibility criteria, and locations as before.SummaryDifference0.5%

- Check63 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is to inform users about potential delays and current availability, aligning with an updated software release.SummaryDifference3%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.